Heart Attack Diagnostics Market Analysis

End-user (Hospitals & Clinics, Diagnostic Center, Ambulatory & Surgical Centers)

The global heart attack diagnostics market is segmented and analyzed for demand and supply by end-user into hospitals & clinics, diagnostic center, and ambulatory & surgical centers. Out of which, the hospitals & clinics segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the high number of surgical procedures performed in hospital settings, and the high number of hospitals present in the world. It was observed that more than 850,000 cardiac surgeries are performed each year in the United States. Moreover, the rising number of heart patient admissions in hospitals along with the increasing pharma sector is anticipated to augment segment growth over the forecast period.

Test (Electrocardiography, Blood Tests, Computerized Cardiac Tomography, Echocardiography, Coronary Angiography)

Furthermore, the global heart attack diagnostics market is segmented and analyzed for demand and supply by test into electrocardiography, blood tests, computerized cardiac tomography, echocardiography, coronary angiography, and others. Out of which, the electrocardiography (ECG) segment is projected to witness noteworthy growth over the forecast period. The growth of the segment is boosted by the fact that it is the first and mandatory test that is performed to diagnose heart attack when the patients get admitted to the hospitals. Based on the data provided by the World Health Organization (WHO), it was stated that in 2019, around 17.9 million people across the globe lost their lives owing to cardiovascular diseases (CVDs), out of which, 85% were caused by a heart attack. Hence, such a higher prevalence of heart attacks is estimated to hike the number of echocardiography test performed in the hospitals over the forecast period. Furthermore, there has been advancement in the ECG devices for diagnosing heart attack, and it is expected to drive the growth of the segment in the heart attack diagnostics market.

Our in-depth analysis of the global heart attack diagnostics market includes the following segments:

By Type	Non-Invasive Minimally Invasive
By Test	Electrocardiography Blood Tests Computerized Cardiac Tomography Echocardiography Coronary Angiography Others
By End User	Hospitals & Clinics Diagnostic Center Ambulatory & Surgical Centers

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of heart attack diagnostics is estimated at USD 14.97 billion.

The heart attack diagnostics market size was over USD 14.06 billion in 2024 and is set to cross USD 38.6 billion by the end of 2037, witnessing more than 8.1% CAGR during the forecast period i.e., between 2025-2037. Rise in geriatric population worldwide and prevalence of unhealthy lifestyles among people will drive the market growth.

North America industry is predicted to dominate majority revenue share by 2037, owing to rising incidence of cardiac diseases along with huge spending on healthcare infrastructure by the regional government and other organization that are helpful to facilitate diagnostic equipment at healthcare facilities.

The major players in the market include Abbott Laboratories, ACS Diagnostics, Company, Asahi Kasei Corporation, AstraZeneca PLC, Beckman Coulter, Inc., Hill-Rom Services, Inc, Koninklijke Philips N.V., General Electric Company, Toshiba Corporation, Schiller Americas, inc.

Heart Attack Diagnostics Market Analysis